Intravenous Fluid Therapy in Hospitals

NCT ID: NCT05964283

Last Updated: 2025-05-02

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

372 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-08-01

Study Completion Date

2024-08-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The administration of intravenous fluids plays a crucial role in critically ill patients to support optimal management and ensure patient safety. Knowledge and conceptual frameworks will influence a clinician's accuracy in providing intravenous fluid therapy to patients. Accurate administration of fluid therapy to patients will reduce unwanted side effects and decrease the overall treatment costs during hospitalization. Various considerations in administering intravenous fluid therapy are influenced by a clinician's level of knowledge. In Indonesia, doctors working in hospitals may have different levels of education and professional status. However, it is currently unclear whether these professional differences among doctors influence their knowledge in administering fluids to patients.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Knowledge Level Intravenous Fluid Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

OTHER

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Anesthesia Specialists

Questionnaire

Intervention Type OTHER

This questionnaire consists of (five) main parts. The first part is about personal information, the second part is about fluid administration in various settings (emergency room, operating room, and intensive care unit), the third part is about fluid administration behaviors, the fourth part is about workplace location, and the fifth part is about a case study. Filling out this questionnaire will take approximately 60 minutes of your time.

Anesthesiologist residencies

Questionnaire

Intervention Type OTHER

This questionnaire consists of (five) main parts. The first part is about personal information, the second part is about fluid administration in various settings (emergency room, operating room, and intensive care unit), the third part is about fluid administration behaviors, the fourth part is about workplace location, and the fifth part is about a case study. Filling out this questionnaire will take approximately 60 minutes of your time.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaire

This questionnaire consists of (five) main parts. The first part is about personal information, the second part is about fluid administration in various settings (emergency room, operating room, and intensive care unit), the third part is about fluid administration behaviors, the fourth part is about workplace location, and the fifth part is about a case study. Filling out this questionnaire will take approximately 60 minutes of your time.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* All anesthesiologist residencies and are willing to complete the questionnaire.
* All anesthesia specialists and subspecialists and are willing to complete the questionnaire until finished.

Exclusion Criteria

* All doctors who are unwilling and do not complete the survey questionnaire.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Indonesia University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dita Aditianingsih

Principal Investigator, Anesthesiologist Consultant

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Dita Aditianingsih

Role: PRINCIPAL_INVESTIGATOR

Indonesia University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rumah Sakit Cipto Mangunkusumo

Jakarta Pusat, DKI Jakarta, Indonesia

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Indonesia

References

Explore related publications, articles, or registry entries linked to this study.

Malbrain MLNG, Langer T, Annane D, Gattinoni L, Elbers P, Hahn RG, De Laet I, Minini A, Wong A, Ince C, Muckart D, Mythen M, Caironi P, Van Regenmortel N. Intravenous fluid therapy in the perioperative and critical care setting: Executive summary of the International Fluid Academy (IFA). Ann Intensive Care. 2020 May 24;10(1):64. doi: 10.1186/s13613-020-00679-3.

Reference Type BACKGROUND
PMID: 32449147 (View on PubMed)

McDougall M, Guthrie B, Doyle A, Timmins A, Bateson M, Ridley E, Drummond G, Vadiveloo T. Introducing NICE guidelines for intravenous fluid therapy into a district general hospital. BMJ Open Qual. 2022 Feb;11(1):e001636. doi: 10.1136/bmjoq-2021-001636.

Reference Type BACKGROUND
PMID: 35115322 (View on PubMed)

Finfer S, Myburgh J, Bellomo R. Intravenous fluid therapy in critically ill adults. Nat Rev Nephrol. 2018 Sep;14(9):541-557. doi: 10.1038/s41581-018-0044-0.

Reference Type BACKGROUND
PMID: 30072710 (View on PubMed)

Monnet X, Marik PE, Teboul JL. Prediction of fluid responsiveness: an update. Ann Intensive Care. 2016 Dec;6(1):111. doi: 10.1186/s13613-016-0216-7. Epub 2016 Nov 17.

Reference Type BACKGROUND
PMID: 27858374 (View on PubMed)

Tommasino C. Fluids and the neurosurgical patient. Anesthesiol Clin North Am. 2002 Jun;20(2):329-46, vi. doi: 10.1016/s0889-8537(01)00013-x.

Reference Type BACKGROUND
PMID: 12165997 (View on PubMed)

Rudloff E, Hopper K. Crystalloid and Colloid Compositions and Their Impact. Front Vet Sci. 2021 Mar 31;8:639848. doi: 10.3389/fvets.2021.639848. eCollection 2021.

Reference Type BACKGROUND
PMID: 33869319 (View on PubMed)

Mackenzie DC, Noble VE. Assessing volume status and fluid responsiveness in the emergency department. Clin Exp Emerg Med. 2014 Dec 31;1(2):67-77. doi: 10.15441/ceem.14.040. eCollection 2014 Dec.

Reference Type BACKGROUND
PMID: 27752556 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

IndonesiaUAnes047

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.